AI has reshaped how healthcare companies operate, develop products and sell. This includes marketing strategy, from content development to performance reporting to bringing their messaging to market.

But as companies increasingly lean into AI, an important question remains: Are we using AI to make our B2B marketing more effective, or are we allowing AI to define how we communicate?

The distinction matters. Because while the technology powering healthcare is becoming increasingly sophisticated, the people buying, implementing, and relying on those solutions remain human. That means healthcare marketing communications need to rediscover something it may be losing: human connection.

 

AI Can Improve Marketing. It Cannot Replace Marketing Strategy.

A meaningful difference exists between using AI as a workflow tool and letting it become the foundation of marketing strategy.

The risk emerges when AI-generated outputs begin to substitute for the strategic work itself. When every company uses similar tools, similar prompts, and similar approaches to content creation (think all those generic LinkedIn one-liners and endless corporate blog posts full of jargon!), the market can become saturated with communications that are polished but indistinguishable.

That leads to more content. Less differentiation. And potentially less trust.

With more than four decades of health-tech marketing under my team’s belt, we are shouting this from the rooftop: AI should help marketers execute their B2B strategy more effectively, not determine what the strategy should be.

A strong marketing strategy still requires a clear understanding of the client’s market today, how it could potentially evolve, their audience, competitive landscape, business objectives, bench of thought leaders and the role they should play in communicating messaging, and the unique value the client brings to customers. Those decisions require judgment, context, and human insight. This is particularly important in healthcare.

Digital health and health-tech companies market complex solutions, and while the technology may be sophisticated, the purchasing decision is not purely technological. Stakeholders like health system execs, payer leaders, clinicians, IT execs, or investors clearly have different responsibilities, incentives, and concerns. They are not searching for the latest technology. They are trying to solve real human and technology problems within complex organizations.

And while the standalone technology matters. Its value lies in the thought leadership behind it, which will show prospects and current customers the everyday pain points it can solve. The product story needs to answer fundamental questions such as: Why does this problem matter now? What makes the approach different, and what data or use cases prove it works? Finally, why should someone trust it?

The product must be communicated in the decision-maker’s language.

AI can help organize and explore these questions. It should not be relied upon to answer them without meaningful human involvement. The answers must come from customer understanding, evolving market knowledge, and authentic organizational expertise from product/client success teams, the C-suite, and operational/clinical teams.

The most effective marketing messages make the audience feel understood before it asks them to take action.

 

Authentic Expertise Has Become More Valuable

As AI makes content production faster and more accessible, the value of original, human thought leadership is increasing. We’re seeing this play out in journalism, and now it has come to marketing communications.

This is because content volume is not the same as insight.

Marketing teams should leverage the thought-leadership value their client brings to the table, not blinded AI examples. When a subject matter expert can share lived experience, including real-world business case conversations with health leaders, that content is miles ahead of what AI can produce. Expertise must come from the people who possess it.

This is where communications professionals play a critical role: uncovering insights executives may not recognize as marketable, then translating them into content that resonates with the right audiences.

 

Buyers Are Human, Too

This is the principle I believe healthcare organizations should keep at the center of their marketing strategies. Behind every procurement process, sales conversation, partnership decision, and media interaction is a person.

A person with competing priorities. A person managing organizational pressures. A person trying to understand whether your solution can help.

That person doesn’t need more content just because content is so easy to produce. They need relevant information, credible expertise in the healthcare market, data to back it up, and a clear understanding of why your offering matters, delivered in the format that makes the most sense to them.

That is why I truly believe the health-tech companies that own 2027 market SOV will not necessarily be those that use the most AI for their marketing. They will be the ones that use AI only as a tool to bolster workflows, while preserving the human understanding and direction that make B2B marketing effective in the first place.

At SVM PR and Marketing, we believe communications should be tailored to each organization’s goals, audiences, expertise, and resources. Our diverse teams of senior communications pros help companies direct their marketing by identifying the stories, spokespeople, formats, and channels that best support their business objectives, while combining proven media strategies with emerging platforms and evolving audience behaviors.

AI plays a meaningful role in that work, but it should remain a means to an end. The ultimate objective isn’t to produce more marketing; it’s to communicate more meaningfully with the buyer, industry stakeholders and investors. Marketing: Why AI Should Support Your B2B Strategy, Not Become It